UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

96 NOTCH1 DELETION IN HEPATOCYTES PREDISPOSES TO DIABETES AND LIVER STEATOSIS THROUGH DYSREGULATION OF GENES INVOLVED IN GLUCOSE AND LIPID HOMEOSTASIS

Journal of hepatology, 2012-04, Vol.56, p.S42-S42

2012

Volltextzugriff (PDF)

Hepatitis C virus dysregulates glucose homeostasis by a dual mechanism involving induction of PGC1α and dephosphorylation of FoxO1

Journal of viral hepatitis, 2014-01, Vol.21 (1), p.9-18

2014

Volltextzugriff (PDF)

P0154 : Differential leukocyte count as an adjunctive biomarker of outcome in patients with acute-on-chronic liver failure

Journal of hepatology, 2015-04, Vol.62, p.S360-S360

2015

Volltextzugriff (PDF)

Mer Tyrosine Kinase Regulates the Activation of Myeloid Cells and Innate Immune Responses in Acute-on-Chronic Liver Failure

Journal of hepatology, 2016, Vol.64 (2), p.S143-S143

2016

Volltextzugriff (PDF)

CTLA-4 is a Negative Regulator of T Cell Activation in Acute Liver Failure

Journal of hepatology, 2016, Vol.64 (2), p.S152-S152

2016

Volltextzugriff (PDF)

MER Tyrosine Kinase Positive Tumour Associated Macrophages Are a Novel Therapeutic Target in Hepatocellular Carcinoma

Journal of hepatology, 2016, Vol.64 (2), p.S574-S575

2016

Volltextzugriff (PDF)

Altered Gut Microbial Profile is a Proponent of Bacterial Translocation in Acute-on-Chronic Liver Failure

Journal of hepatology, 2016, Vol.64 (2), p.S453-S454

2016

Volltextzugriff (PDF)

Secretory Leukocyte Protease Inhibitor Drives Hepatic Resolution Responses in Acute Liver Failure through Modulation of the Mer Tyrosine Kinase Pathway

Journal of hepatology, 2016, Vol.64 (2), p.S512-S512

2016

Volltextzugriff (PDF)

O106 : Therapeutic plasma exchange modulates innate immune activation and improves outcome in patients with acute liver failure

Journal of hepatology, 2015-04, Vol.62, p.S246-S247

2015

Volltextzugriff (PDF)

P1294 : Proof-of-principle evaluation of immunomodulatory drugs in promoting phagocytosis capacity in patients with liver failure

Journal of hepatology, 2015-04, Vol.62, p.S324-S324

2015

Volltextzugriff (PDF)

P0497 : Secretory leukocyte protease inhibitor (SLPI) suppresses innate immune responses and promotes resolution of inflammation in an auto/paracrine manner during acute liver failure (ALF)

Journal of hepatology, 2015-04, Vol.62, p.S500-S501

2015

Volltextzugriff (PDF)

P847 DAYTIME SLEEPINESS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IS LINKED TO INSULIN RESISTANCE, ELEVATED LIVER FUNCTION TESTS AND FIBROSIS

Journal of hepatology, 2014-04, Vol.60 (1), p.S354-S354

2014

Volltextzugriff (PDF)

1316 GLUCOSE-INDUCED GLUCAGON-LIKE PEPTIDE 1 SECRETION IS DEFICIENT IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE

Journal of hepatology, 2013-04, Vol.58, p.S531-S531

2013

Volltextzugriff (PDF)

P164 MONOCYTE EXHAUSTION: A MECHANISTIC EXPLANATION FOR SUSCEPTIBILITY TO INFECTION IN LIVER FAILURE

Journal of hepatology, 2014-04, Vol.60 (1), p.S120-S121

2014

Volltextzugriff (PDF)

P306 MONOCYTE OXIDATIVE BURST DEFECT PREDICTS RISK OF INFECTION IN ALCOHOLIC HEPATITIS

Journal of hepatology, 2014-04, Vol.60 (1), p.S168-S168

2014

Volltextzugriff (PDF)

317 DYSREGULATION OF GLUCONEOGENESIS IN CHRONIC HEPATITIS C: THE ROLE OF PROTEIN PHOSPHATASE 2A

Journal of hepatology, 2009, Vol.50, p.S123-S124

2009

Volltextzugriff (PDF)

614 S-ADENOSYL-METHIONINE (SAME) IMPROVES EARLY VIROLOGICAL RESPONSE IN CHRONIC HEPATITIS C PATIENTS WITH PREVIOUS NON-RESPONSE

Journal of hepatology, 2009, Vol.50, p.S226-S226

2009

Volltextzugriff (PDF)

Braucht es so viele Leberbiopsien? - Replik

Forum médical suisse (En ligne), 2011-03, Vol.11 (9)

2011

Volltextzugriff (PDF)

Stéatose hépatique non alcoolique et stéatohépatite non alcoolique

Forum médical suisse (En ligne), 2011-01, Vol.11 (4)

2011

Volltextzugriff (PDF)

Peginterferon-α-2a (40KD) and Ribavirin for 16 or 24 Weeks in Patients With Genotype 2 or 3 Chronic Hepatitis C

Gastroenterology (New York, N.Y. 1943), 2005-08, Vol.129 (2), p.522-527

2005

Volltextzugriff (PDF)

Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C

Gastroenterology (New York, N.Y. 1943), 2005-08, Vol.129 (2), p.522-527

2005

Volltextzugriff (PDF)

PTH-106 Plasma S100A8/A9: a novel mechanistic biomarker in innate immune activation in acute-on-chronic liver failure

Gut, 2018-06, Vol.67 (Suppl 1), p.A131

2018

Volltextzugriff (PDF)

SAT-019 - AXL-expressing monocytes indicate immuneparesis and disease severity in patients with cirrhosis

Journal of hepatology, 2018-04, Vol.68, p.S613-S613

2018

Volltextzugriff (PDF)

AXL-expressing monocytes indicate immuneparesis and disease severity in patients with cirrhosis

Journal of hepatology, 2018-04, Vol.68, p.S613

2018

Volltextzugriff (PDF)

AODTU-007 Mertk expressing hepatic macrophages promote the resolution of inflammation in acute liver failure

Gut, 2017-07, Vol.66 (Suppl 2), p.A48

2017

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(45)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

96 NOTCH1 DELETION IN HEPATOCYTES PREDISPOSES TO DIABETES AND LIVER STEATOSIS THROUGH DYSREGULATION OF GENES INVOLVED IN GLUCOSE AND LIPID HOMEOSTASIS

Hepatitis C virus dysregulates glucose homeostasis by a dual mechanism involving induction of PGC1α and dephosphorylation of FoxO1

P0154 : Differential leukocyte count as an adjunctive biomarker of outcome in patients with acute-on-chronic liver failure

Mer Tyrosine Kinase Regulates the Activation of Myeloid Cells and Innate Immune Responses in Acute-on-Chronic Liver Failure

CTLA-4 is a Negative Regulator of T Cell Activation in Acute Liver Failure

MER Tyrosine Kinase Positive Tumour Associated Macrophages Are a Novel Therapeutic Target in Hepatocellular Carcinoma

Altered Gut Microbial Profile is a Proponent of Bacterial Translocation in Acute-on-Chronic Liver Failure

Secretory Leukocyte Protease Inhibitor Drives Hepatic Resolution Responses in Acute Liver Failure through Modulation of the Mer Tyrosine Kinase Pathway

O106 : Therapeutic plasma exchange modulates innate immune activation and improves outcome in patients with acute liver failure

P1294 : Proof-of-principle evaluation of immunomodulatory drugs in promoting phagocytosis capacity in patients with liver failure

P0497 : Secretory leukocyte protease inhibitor (SLPI) suppresses innate immune responses and promotes resolution of inflammation in an auto/paracrine manner during acute liver failure (ALF)

P847 DAYTIME SLEEPINESS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IS LINKED TO INSULIN RESISTANCE, ELEVATED LIVER FUNCTION TESTS AND FIBROSIS

1316 GLUCOSE-INDUCED GLUCAGON-LIKE PEPTIDE 1 SECRETION IS DEFICIENT IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE

P164 MONOCYTE EXHAUSTION: A MECHANISTIC EXPLANATION FOR SUSCEPTIBILITY TO INFECTION IN LIVER FAILURE

P306 MONOCYTE OXIDATIVE BURST DEFECT PREDICTS RISK OF INFECTION IN ALCOHOLIC HEPATITIS

317 DYSREGULATION OF GLUCONEOGENESIS IN CHRONIC HEPATITIS C: THE ROLE OF PROTEIN PHOSPHATASE 2A

614 S-ADENOSYL-METHIONINE (SAME) IMPROVES EARLY VIROLOGICAL RESPONSE IN CHRONIC HEPATITIS C PATIENTS WITH PREVIOUS NON-RESPONSE

Braucht es so viele Leberbiopsien? - Replik

Stéatose hépatique non alcoolique et stéatohépatite non alcoolique

Peginterferon-α-2a (40KD) and Ribavirin for 16 or 24 Weeks in Patients With Genotype 2 or 3 Chronic Hepatitis C

Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C

PTH-106 Plasma S100A8/A9: a novel mechanistic biomarker in innate immune activation in acute-on-chronic liver failure

SAT-019 - AXL-expressing monocytes indicate immuneparesis and disease severity in patients with cirrhosis

AXL-expressing monocytes indicate immuneparesis and disease severity in patients with cirrhosis

AODTU-007 Mertk expressing hepatic macrophages promote the resolution of inflammation in acute liver failure

Suchergebnisse filtern